Study finds African-Americans at higher risk for diabetic vision loss
Research by Keck Medicine of USC ophthalmology scientists demonstrates that African Americans bear heavier burden of diabetic macular edema (DME), one of the leading causes of blindness in diabetic...
View ArticleMouse studies advance treatment for common eye diseases
Working with mice, a multicenter team of researchers has found a new way to reduce the abnormal blood vessel growth and leakage in the eye that accompany some eye diseases. The finding could lead to...
View ArticleCaustic ingestion can be mistaken for anaphylaxis
(HealthDay)—For children presenting with an unclear history, caustic ingestion (CI) can be mistaken for anaphylaxis due to similarity of symptoms, according to two case reports published online Jan. 12...
View ArticleEcuadoran beauty queen dies following liposuction
A young beauty queen has died in Ecuador after undergoing liposuction surgery that she had received as a prize, her family said, calling the operation a case of medical malpractice.
View ArticleLucentis approved for diabetic retinopathy
(HealthDay)—A drug to treat the most common eye disease among diabetics has been approved by the U.S. Food and Drug Administration.
View ArticleEylea outperforms other drugs for diabetic macular edema with moderate vision...
In an NIH-supported clinical trial comparing three drugs for diabetic macular edema (DME), Eylea (aflibercept) provided greater visual improvement, on average, than did Avastin (bevacizumab) or...
View ArticleRanibizumab reverses vision loss caused by diabetes
Ranibizumab, a prescription drug commonly used to treat age-related vision loss, also reverses vision loss caused by diabetes among Hispanic and non-Hispanic whites, according to a new study led by...
View ArticleDetecting eye diseases using smartphone technology
Researchers at the Medical and Surgical Center for Retina have developed software that detects eye diseases such as diabetic macular edema using a smartphone. The system is aimed at general physicians...
View ArticleRanibizumab found effective against diabetic retinopathy
In a randomized clinical trial of more than 300 participants, researchers from Johns Hopkins and elsewhere have found that ranibizumab—a drug most commonly used to treat retinal swelling in people with...
View ArticleStudy suggests sildenafil may relieve severe form of edema in swimmers
Swimmers and divers who are prone to a sudden and potentially life-threatening form of pulmonary edema in cold water could benefit from a simple and readily available dose of sildenafil, according to...
View ArticleEylea outperforms Avastin for diabetic macular edema with moderate or worse...
A two-year clinical trial that compared three drugs for diabetic macular edema (DME) found that gains in vision were greater for participants receiving the drug Eylea (aflibercept) than for those...
View ArticleHigh-priced drugs used to treat diabetic macular edema not cost-effective
The anti-vascular endothelial growth factor drugs ranibizumab and aflibercept, used to treat vision loss from diabetic macular edema (DME), and approximately 20 to 30 times more expensive than...
View ArticleVision-threatening stages of diabetic retinopathy associated with higher risk...
In a study published online by JAMA Ophthalmology, Gwyneth Rees, Ph.D., of the University of Melbourne, Australia, and colleagues examined the association between severity of diabetic retinopathy and...
View ArticleImmersion pulmonary edema may cause swimming deaths during triathlons
Heart abnormalities linked to immersion pulmonary edema were present in a greater-than-expected proportion of triathletes who died during the competition's swim portion, according to a study led by...
View ArticleStudy examines use of deep machine learning for detection of diabetic...
In an evaluation of retinal photographs from adults with diabetes, an algorithm based on deep machine learning had high sensitivity and specificity for detecting referable diabetic retinopathy,...
View ArticleAflibercept rescues vision after laser for diabetic macular edema
(HealthDay)—For eyes experiencing substantial visual loss after macular laser photocoagulation treatment for diabetic macular edema (DME), intravitreal aflibercept improves visual and anatomic...
View ArticleTreating traumatic brain injury
After a traumatic brain injury (TBI), the brain produces an inflammatory response. This prolonged swelling is known as cerebral edema and can be fatal. Unfortunately, the only medications available...
View ArticleResearch suggests way to improve stroke treatments
The standard of care for treating strokes caused by blood clots involves the therapeutic infusion of tissue plasminogen activator (tPA), which can help to dissolve the clots and restore blood flow....
View ArticleRed 'color channel' may aid in screening for diabetic eye disease
In photographs of the eye used to screen for diabetes-related eye disease, separating out the red color channel can help show some abnormalities—especially in racial/ethnic minority patients, suggests...
View ArticleTotal retinal blood flow lower in diabetic macular edema
(HealthDay)—Total retinal blood flow (TRBF) is significantly lower in eyes of patients with diabetic macular edema (DME), according to a study published online Feb. 9 in JAMA Ophthalmology.
View ArticleRepeated eye injections for age-related macular degeneration associated with...
Patients with age-related macular degeneration who received seven or more eye injections of the drug bevacizumab annually had a higher risk of having glaucoma surgery, according to a study published...
View ArticleNew approach uses ultrasound to measure fluid in the lungs
A team of engineering and medical researchers has found a way to use ultrasound to monitor fluid levels in the lung, offering a noninvasive way to track progress in treating pulmonary edema – fluid in...
View ArticlePotential new treatment strategy for neuroinflammation related to severe type...
Scientists have discovered a potential new treatment strategy to reduce the effects of intracerebral hemorrhage (ICH), a severe form of stroke where a blood vessel bursts and bleeds into the brain,...
View ArticleAvastin as effective as Eylea for treating central retinal vein occlusion
Monthly eye injections of Avastin (bevacizumab) are as effective as the more expensive drug Eylea (aflibercept) for the treatment of central retinal vein occlusion (CRVO), according to a clinical trial...
View ArticleSleep apnea may increase risk of pregnancy complications
Women with obstructive sleep apnea (OSA) appear to be at greater risk for serious pregnancy complications, longer hospital stays and even admission to the ICU than mothers without the condition,...
View ArticleProtein prevents excess fluid from entering lung tissue
A protein found in the cells lining blood vessels plays a central role in preventing fluid and inflammatory cells from leaking into lung tissue in a low-oxygen environment, Weill Cornell Medicine...
View ArticleUltrasound findings correlate with inflammatory myopathies
(HealthDay)—Ultrasonography findings seem to correlate well with the disease activity of idiopathic inflammatory myopathies (IIMs), and may be a useful tool for patient evaluation, according to a study...
View ArticleWorld's largest clinical specialty database yields critical insights
The American Academy of Ophthalmology today announced key milestones and clinical insights from studies powered by its clinical database. The IRIS Registry (Intelligent Research In Sight) has amassed...
View ArticleExercise does not seem to increase bone marrow edema in healthy people
A recent study published in Rheumatology finds that osteitis/bone marrow edema as measured by magnetic resonance imaging was present in healthy people. However, it did not significantly increase due to...
View ArticleTwo cases of progressive cutaneous anthrax described
(HealthDay)—Two cases of cutaneous anthrax which started on the right forearm and progressed are described in a case report published online Dec. 12 in the International Journal of Dermatology.
View Article
